Table of Content




1. Executive Summary


2. Global Cancer Immunotherapy Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cancer Immunotherapy Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Cancer Immunotherapy Market by Technology Type
3.3.1: Monoclonal Antibodies
3.3.2: Cytokines & Immunomodulators
3.3.3: Others

3.4: Global Cancer Immunotherapy Market by Application
3.4.1: Lung Cancer
3.4.2: Breast Cancer
3.4.3: Colorectal Cancer
3.4.4: Melanoma
3.4.5: Prostate Cancer
3.4.6: Head & Neck Cancer
3.4.7: Others


3.5: Global Cancer Immunotherapy Market by End Use
3.5.1: Hospitals
3.5.2: Cancer Research Centers
3.5.3: Clinics
3.5.4: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cancer Immunotherapy Market by Region
4.2: North American Cancer Immunotherapy Market
4.2.1: North American Cancer Immunotherapy Market by Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others
4.2.2: North American Cancer Immunotherapy Market by End Use: Hospitals, Cancer Research Centers, Clinics, and Others

4.3: European Cancer Immunotherapy Market
4.3.1: European Cancer Immunotherapy Market by Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others
4.3.2: European Cancer Immunotherapy Market by End Use: Hospitals, Cancer Research Centers, Clinics, and Others

4.4: APAC Cancer Immunotherapy Market
4.4.1: APAC Cancer Immunotherapy Market by Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others
4.4.2: APAC Cancer Immunotherapy Market by End Use: Hospitals, Cancer Research Centers, Clinics, and Others

4.5: ROW Cancer Immunotherapy Market
4.5.1: ROW Cancer Immunotherapy Market by Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others
4.5.2: ROW Cancer Immunotherapy Market by End Use: Hospitals, Cancer Research Centers, Clinics, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cancer Immunotherapy Market by Technology Type
6.1.2: Growth Opportunities for the Global Cancer Immunotherapy Market by Application
6.1.3: Growth Opportunities for the Global Cancer Immunotherapy Market by End Use
6.1.4: Growth Opportunities for the Global Cancer Immunotherapy Market by Region

6.2: Emerging Trends in the Global Cancer Immunotherapy Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cancer Immunotherapy Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Immunotherapy Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Novartis
7.2: Merck KGaA
7.3: F. Hoffmann-La Roche
7.4: Bayer
7.5: Bristol-Myers Squibb
7.6: AstraZeneca
7.7: Johnson & Johnson
7.8: Eli Lily
7.9: Amgen
7.10: Pfizer